Surgery Partners Financials

Surgery Partners Inc

SGRYNASDAQ

Trade with Public

$15.32

-0.33-2.11%

At close: Aug 4, 5:00 PM EST

$15.31

-0.34-2.17%

Pre-Market: 5:59 AM EST

Earnings: Q2 2026 Earnings in 4 days from now on Mon Aug 10th, before the market open

Conference Call: Conference call scheduled in 4 days at 8:30 AM

Click to view the webcast

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Surgery Partners Financials

Surgery Partners (SGRY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth

Surgery Partners rises after agreeing to sell Idaho Falls hospital stakes for $795 million while reaffirming its 2026 outlook

Vandana Singh

PRO
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est

Surgery Partners (NASDAQ:SGRY) affirms FY2026 sales outlook from $3.350 billion-$3.450 billion to $3.350 billion-$3.450 billion vs $3.408 billion estimate.

Benzinga Newsdesk

PRO
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.411B Est

2026 GuidanceFull year 2026 revenue guidance reaffirmed to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million

Benzinga Newsdesk

PRO
Surgery Partners Q1 Adj. EPS $(0.03) Beats $(0.12) Estimate, Sales $810.900M Beat $797.892M Estimate

Surgery Partners (NASDAQ:SGRY) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.12) by 75 percent. This is a 175 percent decrease over earnings of $0.04 per share from the

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

Surgery Partners Stock Hits 52-Week Low - Here's Why

Surgery Partners (NASDAQ: SGRY) shares drop in premarket as company reports lower than expected earnings and sets cautious 2026 outlook.

Vandana Singh

Earnings: Q2 2026 Earnings in 4 days from now on Mon Aug 10th, before the market open

Conference Call: Conference call scheduled in 4 days at 8:30 AM

Click to view the webcast

Benzinga

Benzinga

Surgery Partners Inc

Surgery Partners Financials

Earnings & Guidance News

Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth

PROSurgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est

PROSurgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.411B Est

PROSurgery Partners Q1 Adj. EPS $(0.03) Beats $(0.12) Estimate, Sales $810.900M Beat $797.892M Estimate

Earnings Scheduled For May 5, 2026

Surgery Partners Stock Hits 52-Week Low - Here's Why

PRO
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.408B Est

PRO
Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.411B Est

PRO
Surgery Partners Q1 Adj. EPS $(0.03) Beats $(0.12) Estimate, Sales $810.900M Beat $797.892M Estimate